DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 802 filers reported holding DANAHER CORPORATION in Q3 2013. The put-call ratio across all filers is 0.51 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $2,154,000 | -23.9% | 27,466 | -2.0% | 2.89% | -18.1% |
| Q2 2016 | $2,832,000 | +5.7% | 28,037 | -0.7% | 3.53% | +5.1% |
| Q1 2016 | $2,679,000 | +5.1% | 28,237 | +2.9% | 3.36% | +3.5% |
| Q4 2015 | $2,549,000 | +3.4% | 27,443 | -5.2% | 3.24% | -2.8% |
| Q3 2015 | $2,466,000 | -26.1% | 28,940 | -25.8% | 3.34% | -12.1% |
| Q2 2015 | $3,339,000 | +0.4% | 39,017 | -0.4% | 3.80% | +2.8% |
| Q1 2015 | $3,325,000 | -3.6% | 39,163 | -2.7% | 3.70% | -5.8% |
| Q4 2014 | $3,450,000 | +11.1% | 40,258 | -1.5% | 3.92% | +8.9% |
| Q3 2014 | $3,105,000 | -4.3% | 40,867 | -0.8% | 3.60% | -1.7% |
| Q2 2014 | $3,244,000 | +3.5% | 41,216 | -1.4% | 3.66% | -1.2% |
| Q1 2014 | $3,135,000 | -4.7% | 41,806 | -1.9% | 3.71% | -1.6% |
| Q4 2013 | $3,289,000 | +7.9% | 42,616 | -3.1% | 3.77% | -0.4% |
| Q3 2013 | $3,048,000 | +4.8% | 43,976 | -4.3% | 3.78% | +4.7% |
| Q2 2013 | $2,909,000 | – | 45,961 | – | 3.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 241,441 | $70,822,000 | 14.94% |
| Defender Capital, LLC. | 143,752 | $42,381,000 | 14.74% |
| Third Point | 2,490,000 | $730,392,000 | 9.51% |
| Riverstone Advisors, LLC | 63,015 | $18,484,000 | 9.49% |
| 11 Capital Partners LP | 96,063 | $28,178,000 | 8.99% |
| Eos Focused Equity Management, L.P. | 34,026 | $9,981,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 187,609 | $55,031,000 | 7.01% |
| Mirova US LLC | 1,242,440 | $364,444,000 | 7.00% |
| Front Street Capital Management, Inc. | 118,397 | $34,729,000 | 6.47% |
| Alphinity Investment Management Pty Ltd | 909,181 | $266,690,000 | 6.21% |